New Alzheimer’s drugs provide hope for patients

New drugs that studies show can slow the progression of Alzheimer’s disease may soon be available to Iowans. The Food and Drug Administration recently gave full approval to the drug Leqembi.  Dr. Lynn Rankin, a clinical neurologist at UnityPoint Health in Des Moines, says researchers have waited three decades for a treatment that could impact […]

View Full Story